LifePoint Health Reports Fourth Quarter and Year-End 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Mizuho Securities Cuts Price target on LifePoint Health (LPNT) Following 2016 EPS Dilution
February 16, 2016 7:00 AM ESTMizuho Securities reiterated a Neutral rating on LifePoint Health (NASDAQ: LPNT), and cut the price target to $59.40 (from $74.00), resulting from the dilution to 2016 EPS and the sharp drop in FCF as a result of its acquisition strategy. Mizuho believes that LPNT is still... More
LifePoint Health (LPNT) Tops Q4 EPS by 10c; Issues Mixed FY16 Outlook
February 12, 2016 7:01 AM ESTLifePoint Health (NASDAQ: LPNT) reported Q4 EPS of $1.16, $0.10 better than the analyst estimate of $1.06. Revenue for the quarter came in at $1.37 billion versus the consensus estimate of $1.37 billion.
GUIDANCE:
LifePoint Health sees FY2016 EPS of $3.65-$3.91, versus the consensus of... More
